CHORDATE MEDICAL HOLDING AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0526 SEK | -17.55% |
|
-18.07% | -67.21% |
| May. 07 | Chordate Medical Receives Patent Approval in the US | CI |
| Mar. 22 | Chordate Medical Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Chordate Medical Holding AB (publ) is a medical technology company based in Sweden. The Company develops treatment method through nerve stimulation for chronic nasal congestion. The Companyâs headquartered is located in Kista, Sweden.
Calendar
2024-05-16
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -67.21% | 2.4M | |
| +12.85% | 229B | |
| +13.88% | 195B | |
| +18.39% | 142B | |
| +28.78% | 109B | |
| +1.67% | 64.85B | |
| +18.24% | 54.33B | |
| +7.04% | 52.09B | |
| +10.83% | 45.15B | |
| +5.94% | 37.39B |
- Stock Market
- Equities
- CMH Stock
- News Chordate Medical Holding AB
- Chordate Medical Gains EU Patent for Chronic Migraine Treatment